Have an account? Log in.
I don't have an account.
RH (NYSE: RH) reported lower-than-expected Q4 results and gave FY26 sales guidance below estimates. Analysts revised price targets.
Top Wall Street analysts changed their outlook on top names. For a complete view of all rating changes, see analyst ratings page.
Morgan Stanley analyst Simeon Gutman maintains RH (NYSE:RH) with a Overweight and lowers the price target from $275 to $240.
Telsey Advisory Group analyst Cristina Fernandez maintains RH (NYSE:RH) with a Market Perform and lowers the price target from $165 to $140.
RH (NYSE:RH) shares are trading lower after it reported worse-than-expected Q4 results and issued FY26 revenue guidance below estimates.
US stock futures higher with Dow up 200 pts, Beyond Meat shares drop after downbeat results; ORIC, RH, Aptiv, Sweetgreen, Nike, and others also decline.
NKE: -10% | Nike shares are trading lower after the company reported Q3 financial results. Also, the company issued Q4 sales guidance below estimates. ORIC: -36% | Oric Pharmaceuticals shares are trading
Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 results and issuing positive guidance for Q1 and FY27.
U.S. stock futures rose on Wednesday following Tuesday’s sharp rebound. Futures of the major benchmark indices were higher.